RightFit Trial Directory

Colorectal Cancer clinical trials in Bethesda, MD

12 recruiting colorectal cancer studies with a site in Bethesda, MD.

All trials in Bethesda, MD · All Colorectal Cancer trials

RecruitingPhase not listedNCT00034216

Collection of Blood From Patients With Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00451022

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 2NCT01174121

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT04222413

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +1 more sites

RecruitingPhase 1NCT04847063

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1NCT06885697

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT00001823

Evaluation for NCI Surgery Branch Clinical Research Protocols

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT02595957

Genomic Services Research Program

Sponsor: National Human Genome Research Institute (NHGRI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT03190941

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT05592626

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Sponsor: Marengo Therapeutics, Inc.

Bethesda, MD · +12 more sites

RecruitingPhase 1 / Phase 2NCT05691491

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +22 more sites

RecruitingPhase not listedNCT05234177

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Sponsor: Tempus AI

Bethesda, MD · +19 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.